tradmap

WVE Earnings Wave Life Sciences Ltd.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$2 -$1 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $57M $113M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$204M -$102M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 -$0 $0 $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $19M $38M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
-$69M -$20M $29M $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–26 of 26
Q3 20262026-09-30-0.302026-10-2710-Q
Q2 20262026-06-30-0.342026-07-3010-Q
Q1 20262026-03-31-0.132026-04-2810-Q
Q4 2025 (derived)2025-12-31-0.292026-02-2610-K
FY 20252025-12-31-1.212026-02-2610-K
Q3 20252025-09-30-0.322025-11-1010-Q
Q2 20252025-06-30-0.312025-07-3010-Q
Q1 20252025-03-31-0.292025-05-0810-Q
Q4 2024 (derived)2024-12-310.262025-03-0410-K
FY 20242024-12-31-0.702025-03-0410-K
Q3 20242024-09-30-0.472024-11-1210-Q
Q2 20242024-06-30-0.252024-08-0810-Q
Q1 20242024-03-31-0.242024-05-1010-Q
Q4 2023 (derived)2023-12-31-0.142024-03-0610-K
FY 20232023-12-31-0.542024-03-0610-K
Q3 20232023-09-300.072023-11-0910-Q
Q2 20232023-06-30-0.202023-08-0310-Q
Q1 20232023-03-31-0.272023-05-0310-Q
Q4 2022 (derived)2022-12-31-0.392023-03-2310-K
FY 20222022-12-31-2.052023-03-2310-K
Q3 20222022-09-30-0.422022-11-1010-Q
Q2 20222022-06-30-0.622022-08-1110-Q
Q1 20222022-03-31-0.62——
FY 20212021-12-31-2.36——
Q3 20212021-09-30-0.12——
Q2 20212021-06-30-0.78——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.